Home / Inspections / 1097496

FDA Inspection 1097496 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3000204650

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on June 27, 2019 in Fayetteville, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fayetteville, AR (United States)

Facility

Other inspections at this facility

  • 976688 (NAI Thu Jun 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 896536 (NAI Thu Sep 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 752377 (NAI Thu Nov 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources